Scientists test Year-Long flu shield in healthy volunteers
NCT ID NCT07225959
Summary
This study aims to see if giving two annual doses of an experimental long-acting antiviral drug called CD388 is safe for healthy adults who tolerated it well in a previous study. Researchers will check if the body starts making antibodies against the drug after repeated doses, which could affect how well it works, and will closely monitor for any side effects. About 400 participants will receive the drug and be followed for 18 months to understand how the drug behaves in the body over time with repeated use.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Floridian Clinical Research
Miami Lakes, Florida, 33016, United States
-
Spartanburg Medical Research
Spartanburg, South Carolina, 29303, United States
-
hVIVO Serviced Limited
London, England, E1 1EQ, United Kingdom
Conditions
Explore the condition pages connected to this study.